Eli Lilly and Company (Lilly; NYSE: LLY) is a U.S.-based global pharmaceutical manufacturer that discovers, develops, and produces medicines for human health. Founded in 1876 and headquartered in Indianapolis, Indiana, the company’s portfolio spans small‑molecule and biologic therapies, with core focus areas including diabetes and metabolic diseases, immunology, oncology, and neuroscience.
Across the chemicals and life‑sciences value chain, Lilly operates extensive R&D and manufacturing networks for active pharmaceutical ingredients (APIs), biologics, and sterile injectable formulations, supported by global quality, regulatory, and supply‑chain systems. The company also develops drug‑delivery devices and collaborates with academic and industry partners to advance new therapeutic modalities.
Official website: lilly.com
chemXplore tracks active investment projects involving Lilly, across sectors such as Basic Chemicals, Biobased & Circular, and Polymers.
Lilly's role is mapped on each — as Owner.
To provide comprehensive coverage, we aggregate data and news under the name Lilly, encompassing the following company names, divisions, and related entities:
Eli Lilly, Lilly USA, and LLY.
This list encompasses current and former names, alternate names, and key divisions associated with Lilly, ensuring you can easily find all relevant information under a single, unified profile.
